DRREDDY:NSE Dr. Reddy's Laboratories Limited

INR 6,140.55 96.45 1.595771
Icon

Dr. Reddy's Laboratories Limited (DRREDDY:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSE
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 6,140.55

+96.45 (+1.60)%

INR 1,023.87B

0.52M

N/A

N/A

Icon

DRREDDY:NSE

Dr. Reddy's Laboratories Limited (INR)
COMMON STOCK | NSE
INR 6,140.55
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 1,023.87B

N/A

INR 6,140.55

Dr. Reddy's Laboratories Limited (DRREDDY:NSE) Stock Forecast

INR 5,740.67
(-6.51%)

Based on the Dr. Reddy's Laboratories Limited stock forecast from 6 analysts, the average analyst target price for Dr. Reddy's Laboratories Limited is INR 5,740.67 over the next 12 months. Dr. Reddy's Laboratories Limited’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Dr. Reddy's Laboratories Limited is Bullish , which is based on 12 positive signals and 2 negative signals. At the last closing, Dr. Reddy's Laboratories Limited’s stock price was INR 6,140.55. Dr. Reddy's Laboratories Limited’s stock price has changed by +0.20% over the past week, -4.47% over the past month and +35.65% over the last year.

No recent analyst target price found for Dr. Reddy's Laboratories Limited
No recent average analyst rating found for Dr. Reddy's Laboratories Limited

Company Overview Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment man...Read More

https://www.drreddys.com

8-2-337, Road No. 3, Hyderabad, India, 500034

25,863

March

INR

India

Adjusted Closing Price for Dr. Reddy's Laboratories Limited (DRREDDY:NSE)

Loading...

Unadjusted Closing Price for Dr. Reddy's Laboratories Limited (DRREDDY:NSE)

Loading...

Share Trading Volume for Dr. Reddy's Laboratories Limited Shares

Loading...

Compare Performance of Dr. Reddy's Laboratories Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for DRREDDY:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Dr. Reddy's Laboratories Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SUNPHARMA:NSE
Sun Pharmaceutical Industries .. +16.40 (+1.02%) INR3,736.24B 41.91 27.03

ETFs Containing DRREDDY

Symbol Name DRREDDY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Dr. Reddy's Laboratories Limited (DRREDDY:NSE) Stock

Based on ratings from 6 analysts Dr. Reddy's Laboratories Limited's stock is Hold . Stock Target Advisor's fundamental analysis is Bullish . The stock has 2 buy, 1 sell and 6 hold ratings.

DRREDDY:NSE stock's dividend yield is 0.66%. Our analysis grades DRREDDY:NSE stock's dividend yield at D-. This means that DRREDDY:NSE stock's dividend yield is above 60% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this DRREDDY:NSE may be a average dividend stock for its sector.

Based on targets from 6 analysts, the average taret price for DRREDDY:NSE is INR 5,740.67 over the next 12 months. The maximum analyst target price is INR 6000 while the minimum anlayst target price is INR 5400.

DRREDDY:NSE stock's Price/Earning ratio is 19.63. Our analysis grades DRREDDY:NSE stock's Price / Earning ratio at B-. This means that DRREDDY:NSE stock's Price/Earning ratio is above 18.99999999999999% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this DRREDDY:NSE may be undervalued for its sector.

The last closing price of DRREDDY:NSE's stock was INR 6,140.55.

The most recent market capitalization for DRREDDY:NSE is INR 1,023.87B.

Based on targets from 6 analysts, the average taret price for DRREDDY:NSE is projected at INR 5,740.67 over the next 12 months. This means that DRREDDY:NSE's stock price may go down by -6.51% over the next 12 months.

We can't find any ETFs which contains Dr. Reddy's Laboratories Limited's stock.

As per our most recent records Dr. Reddy's Laboratories Limited has 25,863 Employees.

Dr. Reddy's Laboratories Limited's registered address is 8-2-337, Road No. 3, Hyderabad, India, 500034. You can get more information about it from Dr. Reddy's Laboratories Limited's website at https://www.drreddys.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...